Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul 15;8(7):10491-500.
eCollection 2015.

Protective effect of resveratrol against methotrexate-induced oxidative stress in the small intestinal tissues of rats

Affiliations

Protective effect of resveratrol against methotrexate-induced oxidative stress in the small intestinal tissues of rats

Aynur Arslan et al. Int J Clin Exp Med. .

Abstract

The effect of resveratrol on the damage induced by methotrexate (MTX) in rat duodenum and jejunum tissue was investigated and evaluated in comparison with famotidine. The rats were divided into four groups as healthy group (HG), resveratrol+MTX (RMTX) group, famotidine+MTX (FMTX) group and the control group which received MTX (MTXC). RMTX group was given resveratrol 25 mg/kg and FMTX group famotidin 25 mg/kg, while MTXC and HG groups were orally administered distilled water once a day for 30 days. The rats in RMTX, FMTX and MTXC groups were given MTX of 5 mg/kg dose by the same way for 30 days. At the end of this period, amount of MDA, 8-OH/Gua and tGSH, and MPO gene expression were measured in the duodenal and jejunal tissues and the results were histopathologically evaluated. Resveratrol and famotidine were found to significantly prevent elevation of the MDA, 8-OH/Gua and MPO parameters with MTX and decrease of the levels of tGSH in the duodenal and jejunal tissues. Both drugs prevented severe damage to the villus and crypt epithelium in the duodenum and jejunum, congestion and hemorrhage, inflammatory cell infiltration and necrosis in the mucosa and submucosa due to MTX administration. Resveratrol could be considered in the clinical practice for treatment of the tissue damage in the intestines due to use of MTX, in comparison with famotidine. Resveratrol may be more advantageous than famotidine in long-term use against MTX toxicity since it does not inhibit gastric acid secretion.

Keywords: Resveratrol; oxidative stress; small intestine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The effects of Resveratrol and Famotidin on MDA, tGSH and 8-OH/Gua levels in the duodenal tissues of rats given methotrexate. Bars are mean ± SEM. RMTX, FMTX and HG groups are compared with MTXC group. **: P<0.001.
Figure 2
Figure 2
The effects of Resveratrol and Famotidin on MDA, tGSH and 8-OH/Gua levels in the jejunal tissue of rats given methotrexate. Bars are mean ± SEM. RMTX, FMTX and HG groups are compared with MTXC group. **: P<0.001.
Figure 3
Figure 3
The effects of Resveratrol and Famotidin on MPO gene expression in the duodenal and jejunal tissues of rats given MTX. RMTX, FMTX and HG groups are compared with MTXC group. **: P<0.001.
Figure 4
Figure 4
A. The histo-pathological examination of the duodenum tissue of healthy group (HG), (H&E ×100), B. The histo-pathological examination of the jejunum tissue of healthy group (HG), (H&E ×100).
Figure 5
Figure 5
A. Section of the duodenum tissue of MTXC group (H&E ×400), B. Section of the duodenum tissue of MTXC group (H&E ×200), C. Section of the duodenum tissue of MTXC group (H&E ×400), D. Section of the duodenum tissue of MTXC group (H&E ×100), E. Section of the duodenum tissue of RMTX group (H&E ×100), F. Section of the duodenum tissue of FMTX group (H&E ×100).
Figure 6
Figure 6
A. Section of the jejunum tissue of MTXC group (H&E ×400), B. Section of the jejunum tissue of MTXC group (H&E ×400), C. Section of the jejunum tissue of RMTX group (H&E ×100), D. Section of the jejunum tissue of FMTX group (H&E ×100).

Similar articles

Cited by

References

    1. Cetinkaya A, Bulbuloglu E, Kurutas EB, Kantarceken B. N-acetylcysteine ameliorates methotrexate-induced oxidative liver damage in rats. Med Sci Monit. 2006;12:BR274–278. - PubMed
    1. Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chabner BA. The pharmacology and clinical use of methotrexate. N Engl J Med. 1983;309:1094. - PubMed
    1. Nagakubo J, Tomimatsu T, Kitajima M, Takayama H, Aimi N, Horie T. Characteristics of transport of fluoresceinated methotrexate in rat small intestine. Life Sci. 2001;69:739–747. - PubMed
    1. Loehry C, Creamer B. Three-demensional structure of the rat small intestinal mucosa related to mucosal dynamics. II. Mucosal structure and dynamics in the lactating rat. Gut. 1969;10:116–118. - PMC - PubMed
    1. Taminiau J, Gall D, Hamilton J. Response of the rat small-intestine epithelium to methotrexate. Gut. 1980;21:486–492. - PMC - PubMed

LinkOut - more resources